2m 2m 2m 2m 2m 2m 2m
ERNEXA THERAPE (ERNA)
NASDAQ
$8.16+$0.16 (+1.95%)
Price as of Jun 03, 2026 7:43 PM EDT- $12.3MMarket Cap
- -88.13%1-Year Change
- BiotechnologyIndustry
ERNEXA THERAPE (ERNA)
$8.16+$0.16 (+1.95%)
ERNA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.00 | ||
Change | -$1.12 (-12.28%) | ||
Open | $9.08 | ||
High | $9.10 | ||
Low | $8.00 | ||
Previous Close | $9.12 | ||
Volume | 54,537 | ||
30-Day Average Volume | 4,790,245 | ||
1-Week Change | -30.01% | ||
1-Month Change | 109.84% | ||
1-Year Change | -88.13% | ||
3-Year Change | -98.93% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.2M | ||
Total Assets | $10.5M | ||
Market Cap | $12.3M | ||
Enterprise Value | $4.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$2.3M | ||
EBIT | -$40,000.00 | ||
EBITDA | -$32,000.00 | ||
Net Working Capital | $6.5M | ||
EPS | -$173.75 | ||
Enterprise Value/EBITDA | -151 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -0 | ||
PEG | N/A | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 05/04/2026 | ||
Earnings & Revenue